Literature DB >> 18936058

An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture.

Sean C Bendall1, Chris Hughes, J Larry Campbell, Morag H Stewart, Paula Pittock, Suya Liu, Eric Bonneil, Pierre Thibault, Mickie Bhatia, Gilles A Lajoie.   

Abstract

The derivation and long-term maintenance of human embryonic stem cells (hESCs) has been established in culture formats that are both dependent and independent of support (feeder) cells. However, the factors responsible for preserving the viability of hESCs in a nascent state remain unknown. We describe a mass spectrometry-based method for probing the secretome of the hESC culture microenvironment to identify potential regulating protein factors that are in low abundance. Individual samples were analyzed several times, using successive mass (m/z) and retention time-directed exclusion, without sampling the same peptide ion twice. This iterative exclusion -mass spectrometry (IE-MS) approach more than doubled protein and peptide metrics in comparison to a simple repeat analysis method on the same instrument, even after extensive sample pre-fractionation. Furthermore, implementation of the IE-MS approach was shown to enhance the performance of an older quadrupole time of flight (Q-ToF) MS. The resulting number of identified peptides approached that of a parallel repeat analysis on a newer LTQ-Orbitrap MS. The combination of the results of both instruments proved to be superior to that achieved by a single instrument in the identification of additional proteins. Using the IE-MS strategy, combined with complementary gel- and solution-based fractionation methods, the hESC culture microenvironment was extensively probed. Over 10 to 12 times more extracellular proteins were observed compared with previously published surveys. The detection of previously undetectable growth factors, present at concentrations ranging from 10(-9) to 10(-11) g/ml, highlights the depth of our profiling. The IE-MS approach provides a simple and reliable technique that greatly enhances instrument performance by increasing the effective depth of MS-based proteomic profiling. This approach should be widely applicable to any LC-MS/MS instrument platform or biological system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936058      PMCID: PMC2649806          DOI: 10.1074/mcp.M800190-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  33 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

Review 2.  Mass spectrometry-based proteomics.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

3.  Approaching complete peroxisome characterization by gas-phase fractionation.

Authors:  Eugene C Yi; Marcello Marelli; Hookeun Lee; Samuel O Purvine; Ruedi Aebersold; John D Aitchison; David R Goodlett
Journal:  Electrophoresis       Date:  2002-09       Impact factor: 3.535

4.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.

Authors:  B E Reubinoff; M F Pera; C Y Fong; A Trounson; A Bongso
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

5.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

6.  Feeder-free growth of undifferentiated human embryonic stem cells.

Authors:  C Xu; M S Inokuma; J Denham; K Golds; P Kundu; J D Gold; M K Carpenter
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

7.  A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling.

Authors:  Blagoy Blagoev; Irina Kratchmarova; Shao-En Ong; Mogens Nielsen; Leonard J Foster; Matthias Mann
Journal:  Nat Biotechnol       Date:  2003-02-10       Impact factor: 54.908

8.  Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells.

Authors:  Justin Wee Eng Lim; Andrea Bodnar
Journal:  Proteomics       Date:  2002-09       Impact factor: 3.984

9.  Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Jawon Seo; Jaeho Jeong; Young Mee Kim; Narae Hwang; Eunok Paek; Kong-Joo Lee
Journal:  J Proteome Res       Date:  2008-02       Impact factor: 4.466

10.  Nonredundant mass spectrometry: a strategy to integrate mass spectrometry acquisition and analysis.

Authors:  Alexander Scherl; Patrice Francois; Véronique Converset; Manuela Bento; Jennifer A Burgess; Jean-Charles Sanchez; Denis F Hochstrasser; Jacques Schrenzel; Garry L Corthals
Journal:  Proteomics       Date:  2004-04       Impact factor: 3.984

View more
  24 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

2.  Expanding Lipidome Coverage Using LC-MS/MS Data-Dependent Acquisition with Automated Exclusion List Generation.

Authors:  Jeremy P Koelmel; Nicholas M Kroeger; Emily L Gill; Candice Z Ulmer; John A Bowden; Rainey E Patterson; Richard A Yost; Timothy J Garrett
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-06       Impact factor: 3.109

Review 3.  The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Authors:  Malgorzata Klauzinska; Nadia P Castro; Maria Cristina Rangel; Benjamin T Spike; Peter C Gray; Daniel Bertolette; Frank Cuttitta; David Salomon
Journal:  Semin Cancer Biol       Date:  2014-08-19       Impact factor: 15.707

4.  Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Authors:  Lan Dai; Jintang He; Yashu Liu; Jaeman Byun; Anuradha Vivekanandan; Subramaniam Pennathur; Xing Fan; David M Lubman
Journal:  Proteomics       Date:  2011-10-24       Impact factor: 3.984

5.  Targeted proteomics of the secretory pathway reveals the secretome of mouse embryonic fibroblasts and human embryonic stem cells.

Authors:  Prasenjit Sarkar; Shan M Randall; David C Muddiman; Balaji M Rao
Journal:  Mol Cell Proteomics       Date:  2012-09-15       Impact factor: 5.911

6.  Mass spectrometry-based proteomic analysis of the matrix microenvironment in pluripotent stem cell culture.

Authors:  Chris Hughes; Lida Radan; Wing Y Chang; William L Stanford; Dean H Betts; Lynne-Marie Postovit; Gilles A Lajoie
Journal:  Mol Cell Proteomics       Date:  2012-09-27       Impact factor: 5.911

Review 7.  Role of Cripto-1 in stem cell maintenance and malignant progression.

Authors:  Caterina Bianco; Maria Cristina Rangel; Nadia P Castro; Tadahiro Nagaoka; Kelly Rollman; Monica Gonzales; David S Salomon
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

8.  Nonmitogenic survival-enhancing autocrine factors including cyclophilin A contribute to density-dependent mouse embryonic stem cell growth.

Authors:  Nikhil Mittal; Joel Voldman
Journal:  Stem Cell Res       Date:  2010-10-20       Impact factor: 2.020

9.  A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells.

Authors:  Matthew J Birket; Adam L Orr; Akos A Gerencser; David T Madden; Cathy Vitelli; Andrzej Swistowski; Martin D Brand; Xianmin Zeng
Journal:  J Cell Sci       Date:  2011-02-01       Impact factor: 5.285

10.  Proteins secreted by embryonic stem cells activate cardiomyocytes through ligand binding pathways.

Authors:  W A LaFramboise; P Petrosko; J M Krill-Burger; D R Morris; A R McCoy; D Scalise; D E Malehorn; R D Guthrie; M J Becich; R Dhir
Journal:  J Proteomics       Date:  2010-01-04       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.